Prostate cancer is the second leading … treated at an early stage, prostate cancer is often curable. However, … such as metastatic castration-resistant prostate cancer (mCRPC) has a high … were on docetaxel, cabaxitaxel, mitoxantrone, and sipuleucel-T either before …

… metastatic castration-resistant prostate cancer (mCRPC), according to … with metastatic castration-resistant prostate cancer,” said Neeraj Agarwal, … inhibitor, cyclophosphamide, or mitoxantrone for prostate cancer; clinically significant cardiovascular …

… Key Updates to the NCCN Prostate Cancer Guidelines that were published on … such as docetaxel, cabazitaxel, and mitoxantrone. We also have immunotherapy agents … ARPIs for metastatic hormone-sensitive prostate cancer in 3% of the population …

… or mitoxantrone plus prednisone for advanced prostate cancer. N … hormone-sensitive metastatic prostate cancer: evidences and uncertainties … complexity of the prostate cancer microenvironment influences the … molecular imaging of prostate cancer with PSMA-targeted …

… deaths. Death from prostate cancer is associated with metastasis … cell population of prostate cancer, called DU145J7 with … 0-fold resistant to mitoxantrone, daunorubicin, and gimatecan … sensitivity of DU145J7 prostate cancer cells to chromatin modifying …

… prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl … compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N … cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after …

… for Metastatic Castration-resistant Prostate Cancer Prostate Cancer Theranostics: PSMA Targeted … or Mitoxantrone for Metastatic Castration-resistant Prostate Cancer Progressing … positive Metastatic Castration-resistant Prostate Cancer: Prior and Concomitant …

… just docetaxel and mitoxantrone. It seems … (NCCN Guidelines®) Prostate Cancer. Patient-Reported Outcomes … Metastatic, Castration-Resistant Prostate Cancer (PROSPER): A … Prostate Cancer Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer …

… T-cells in prostate tumors, and lower … or mitoxantrone for metastatic castration-resistant prostate cancer … metastatic castration-resistant prostate cancers: a randomised, … prostate cancer: clinical implications and therapeutic targeting. Prostate Cancer …

… localized prostate cancer is asymptomatic; however, prostate cancer … agents for prostate cancer. Prostate cancer, the … = 7).8 Prostate cancers are typically divided … mitoxantrone, or estramustine.6 For example, in castration-naïve metastatic prostate cancer …